-
Mashup Score: 4One in Five Patients Admitted With COVID-19 Die in the Hospital - 3 year(s) ago
Prognosis is poor for those with CV risk factors/comorbidities, but complications like PE and DVT are less frequent than expected.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 6Intravenous iron reduces HF readmissions: AFFIRM-AHF - 4 year(s) ago
The results are likely to change heart failure guidelines, which currently give a lukewarm recommendation for intravenous iron in the US, experts say.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
AFFIRM-AHF Trial: Iron supplementation reduced the risk of total HF hospitalizations and cardiovascular death by 21% in iron-deficient patients. https://t.co/zNKgkF29GY @umed_wroc @UofGlasgow @NMHheartdoc @BrighamWomens @DrNancySweitzer #AHA20 #AHA2020 https://t.co/ROlOlMMtlm
-
-
Mashup Score: 4
“You’re seeing a paradigm shift right here in front of your eyes today. This could be a game changer in terms of preventing large numbers of cardiovascular events.” —Dr. Donald Lloyd-Jones
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
TIPS-3 Trial: A once-daily polypill reduced major cardiovascular events by 21% and when adding 75 mg of aspirin the risk reduction was increased to 31%. https://t.co/dRtvmnUpnw #AHA20 #AHA2020 https://t.co/K0M6X089Pe
-
-
Mashup Score: 0
Omecamtiv mecarbil safely met its primary efficacy endpoint in patients with heart failure with reduced ejection fraction in GALACTIC-HF, but with a modest effect.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#AHA20: Omecamtiv mecarbil safely produced significant improvement in #HFrEF in the GALACTIC-HF trial. via https://t.co/nVha9SIoE2 #AHA2020 @HeartNews @jteerlinkmd @paheidenreich @WashU_cards https://t.co/h2hZdFkDpL
-
-
Mashup Score: 1Don’t miss cardiovascular risk factors in transgender patients - 4 year(s) ago
Transgender patients seeking gender affirming hormone therapy showed an increased risk of cardiovascular disease at baseline
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#AHA20: Cardiovascular risks found in a recent study among transgender patients seeking gender-affirming hormone therapy. via https://t.co/gzrM9P8JNb #AHA2020 @HeartNews @KaraDenbyMD @billycaceres_ https://t.co/x91U6qSD1S
-
-
Mashup Score: 2
Eliminating the need for in-person visits, the initiative could serve as model to expand access and reduce healthcare inequities.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk -- #AHA2020 https://t.co/25U9Jv20u7
-
-
Mashup Score: 3COVID-19 Patients With Cardiovascular Disease Have In-hospital Mortality Rates of 25 to 38 Percent - 4 year(s) ago
November 18, 2020 — A late-breaking study at the 2020 American Heart Association (AHA) Scientific Sessions showed nearly 20,000 patients revealed that cardiovascular disease (CVD) risk factors in COVID-19 (SARS-CoV-2) patients dramatically increased the risk of in-hospital mortality. The risk of death was particularly high for older, nonwhite men.
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
COVID-19 Patients With Cardiovascular Disease Have In-hospital Mortality Rates of 25 to 38 Percent https://t.co/yJBOLxBJHx #COVID19 #SARSCoV2 #cardiotwitter #cardiology #healthcare #heartfailure #HF #AHA20 #AHA2020
-
-
Mashup Score: 0
November 18, 2020 — A new American Heart Association (AHA) collaborative model for COVID-19 (SARS-CoV-2) research, using data from the new AHA COVID-19 Cardiovascular Disease Registry, found hispanic and black adults with COVID-19 were far more likely to be hospitalized than their white counterparts, as were people with obesity and COVID-19, acc
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
COVID-19 Cardiovascular Registry Details Disparities Among Hospitalized Patients https://t.co/ySd6hv15WR #cardiotwitter #cardiology #AHA2020 #COVID19 #SARSCoV2 #HealthDisparities
-
-
Mashup Score: 2Flu vaccination low among young adults with CVD - 4 year(s) ago
In 2018, about one-quarter of adults aged 18 to 34 years with CVD received a flu shot and in those with a history of MI only about 20% were vaccinated, researchers reported at the virtual American Heart Association Scientific Sessions. “For people with cardiovascular disease, it is important to take the necessary steps to protect themselves from flu as there is a high risk of having
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A study presented at #AHA2020 highlights the urgent need to increase #FluVaccination among young adults with #CVD to decrease #morbidity and #mortality. @American_Heart @InfectDisNews @tm_parekh @GeorgeMasonU #CardioTwitter https://t.co/qbM63XqeqY
-
-
Mashup Score: 0AHA: American Heart Association | MDedge Cardiology - 4 year(s) ago
Conference Coverage Cardiac arrest in COVID-19 pandemic: ‘Survival is possible’ Author: Marlene Busko …
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Thank you for spending your #AHA20 time with us. In case you missed any of the key sessions click the link below for our full conference coverage. https://t.co/BExB0cCjwr #AHA2020 https://t.co/1FZKVyHYlK
-
One in Five Patients Admitted With COVID-19 Die in the Hospital https://t.co/oJ9elfhtDs -- with Dr. James de Lemos and @AnnMarieNavar from UT Southwestern (@UTSWNews ). #AHA2020